Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A systematic review with expert opinion on the role of gepants for the preventive and abortive treatment of migraine
Andreas A. Argyriou, Elisa Mantovani, Dimos D. Mitsikostas, et al.
Expert Review of Neurotherapeutics (2022) Vol. 22, Iss. 6, pp. 469-488
Closed Access | Times Cited: 18

Showing 18 citing articles:

Gepants for Acute and Preventive Migraine Treatment: A Narrative Review
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
Brain Sciences (2022) Vol. 12, Iss. 12, pp. 1612-1612
Open Access | Times Cited: 38
Navigating the Neurobiology of Migraine: From Pathways to Potential Therapies
Masaru Tanaka, Bernadett Tuka, László Vécsei
Cells (2024) Vol. 13, Iss. 13, pp. 1098-1098
Open Access | Times Cited: 13
Preferences and perceptions of 617 migraine patients on acute and preventive migraine treatment attributes and clinical trial endpoints
Michail Vikelis, Dimitrios Rikos, Andreas A. Argyriou, et al.
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 8, pp. 815-826
Closed Access | Times Cited: 6
Switching between anti-cgrp monoclonal antibodies in migraine prophylaxis
Michail Vikelis, Dimitrios Rikos, Andreas A. Argyriou, et al.
Expert Review of Neurotherapeutics (2025)
Closed Access
Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study)
Luigi Francesco Iannone, Gloria Vaghi, Gabriele Sebastianelli, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Optogenetic cortical spreading depression originating from the primary visual cortex induces migraine-like pain and anxiety behaviors in freely moving C57BL/6 J mice
Huijuan Yuan, Weinan Na, Bozhi Li, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Migräne
Hartmut Göbel
Springer eBooks (2025), pp. 185-515
Closed Access
Hellenic Headache Society Recommendations for the Use of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide Pathway for the Prevention of Migraine and Cluster Headache—2023 Update
Dimos D. Mitsikostas, A. Alexoudi, Chrysa Arvaniti, et al.
SN Comprehensive Clinical Medicine (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 9
Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine
Emmanouil V. Dermitzakis, Michail Vikelis, Georgia Xiromerisiou, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 386-386
Open Access | Times Cited: 3
Adverse events associated with Atogepant: a faers-based pharmacovigilance analysis
Ying Zhang, Shengzhu Sun, Y. Wang
Expert Opinion on Drug Safety (2024), pp. 1-7
Closed Access | Times Cited: 3
Safety and Efficacy of Zavegepant in Treating Migraine: A Systematic Review
Zainab Khan, Usman Ahmed, Faizan Shahzad, et al.
Cureus (2023)
Open Access | Times Cited: 6
Results of a Web-Based Survey on 2105 Greek Migraine Patients—Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients’ Reported Satisfaction
Emmanouil V. Dermitzakis, Aikaterini Kouroudi, Andreas A. Argyriou, et al.
Medicina (2022) Vol. 59, Iss. 1, pp. 31-31
Open Access | Times Cited: 5
Is the right way to go in between?
Andreas R. Gantenbein, Andreas Kleinschmidt
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 2
TRP channels and migraine
Luigi Francesco Iannone, Romina Nassini, Francesco De Logu, et al.
Elsevier eBooks (2024), pp. 217-228
Closed Access
Real-World Open-Label Experience with Rimegepant for the Acute Treatment of Migraine Attacks: A Multicenter Pilot Study
Emmanouil V. Dermitzakis, Dimitrios Rikos, Michail Vikelis, et al.
Brain Sciences (2024) Vol. 14, Iss. 12, pp. 1169-1169
Open Access
Effect of peppermint essential oil (Mentha piperita L.) in migraine-like responses in female rats
Laura de Oliveira Koren, Vanessa Bordenowsky Pereira Lejeune, Darciane Favero Baggio, et al.
Deleted Journal (2024) Vol. 15, Iss. 2, pp. 78-85
Closed Access
Gepants - new moleculs in migraine treatment
Petra Migaľová
Neurologie pro praxi (2024) Vol. 25, Iss. 6, pp. 466-469
Closed Access
An exploration into the lifeworld of patients with cluster headache in South Africa
Tanya Tschirpig
(2023)
Open Access | Times Cited: 1
Zavegepant Nasal Spray for Treatment of Acute Migraine: A Systematic Review
Victor Ameh Odoma, Daniel Nwabueze, Benish Alam, et al.
Journal of Advances in Medicine and Medical Research (2023) Vol. 35, Iss. 16, pp. 69-77
Open Access
Page 1

Scroll to top